Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ARB7
|
|||
| Drug Name |
XENO-Skin
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Burns [ICD-11: N.A.] | Phase 1/2 | [1] | |
| Company |
XenoTherapeutics Boston, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03695939) An Open-label Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of realSKIN? (Skin Xenotransplant) for Complete Closure of Severe and Extensive Deep-Partial and Full-Thickness Burn Wounds. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.